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ABSTRACT Informationonhowemergingpathogenscaninvadeandpersistandspreadwithinhostpopulationsremainssparse.Inthe
1980s,amultidrug-resistantSalmonellaentericaserotypeTyphimuriumclonelysogenizedbyabacteriophagecarryingthesopEviru-
lencegenecausedanepidemicamongcattleandhumansinEurope.Hereweshowthatphage-mediatedhorizontaltransferofthesopE
geneenhancestheproductionofhost-derivednitrate,anenergeticallyhighlyvaluableelectronacceptor,inamousecolitismodel.In
turn,nitratefuelsabloomofS.Typhimuriuminthegutlumenthroughanaerobicnitraterespirationwhilesuppressinggenesforthe
utilizationofenergeticallyinferiorelectronacceptorssuchastetrathionate.Throughthismechanism,horizontaltransferofsopEcan
enhancetheﬁtnessofS.Typhimurium,resultinginitssigniﬁcantlyincreasedabundanceinthefeces.
IMPORTANCE During gastroenteritis, Salmonella enterica serotype Typhimurium can use tetrathionate respiration to edge out
competingmicrobesinthegutlumen.However,theconceptthattetrathionaterespirationconfersagrowthbeneﬁtinthein-
ﬂamedgutisnotbroadlyapplicabletootherhost-pathogencombinationsbecausetetrathionaterespirationisasignaturetrait
usedtodifferentiateSalmonella serotypesfrommostothermembersofthefamily Enterobacteriaceae.Hereweshowthatbyac-
quiringthephage-carried sopEgene,S.Typhimuriumcandrivethehosttogenerateanadditionalrespiratoryelectronacceptor,
nitrate.Nitratesuppressesgenesfortheutilizationofenergeticallyinferiorelectronacceptorssuchastetrathionatewhileen-
hancingtheluminalgrowthof S.Typhimuriumthroughanaerobicnitraterespiration.Pathwaysforanaerobicnitraterespira-
tionarewidelyconservedamongmembersofthefamily Enterobacteriaceae,therebymakingourobservationsrelevanttoother
entericpathogenswhoserelativeabundanceintheintestinallumenincreasesduringinfection.
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T
he ﬁrst human outbreak of a multidrug-resistant (MDR)
pathogen was recorded between 1964 and 1966 in Great Brit-
ain(1).TheoutbreakwascausedbyaSalmonellaentericaserotype
Typhimurium strain which circulated in cattle and had acquired
resistance to furazolidone, ampicillin, chloramphenicol (Cm),
kanamycin (Kan), neomycin, streptomycin, sulfonamides, and
tetracyclines.DifferentiationofS.Typhimuriumisolatesbyphage
typingidentiﬁedtheoutbreakstrainasadistinctclonewithdeﬁn-
itive phage type 29 (DT29) (1). Subsequent surveillance by the
Central Veterinary Laboratory in the United Kingdom revealed
the emergence of several MDR clones over time. Each epidemic
clone, after dominating for a period of time in its bovine animal
reservoir, was eventually replaced, as indicated by the dominance
of a new phage type (reviewed in reference 2). However, the rise
andfallofepidemicS.Typhimuriumphagetypeswerenotaccom-
panied by obvious changes in their antibiotic resistance proﬁles,
suggesting that antibiotic resistance is not the sole property that
enhances the ﬁtness of a newly emergent clone.
Phage types DT204 and DT204c deﬁne an epidemic MDR
S. Typhimurium clone which dominated in Europe in the 1980s
(2). Isolates of this clone are lysogenized by a bacteriophage,
termed SopE, which carries the sopE virulence gene (3, 4). The
SopE prophage is present in only a small fraction of S. Typhi-
murium isolates, including phage types DT204, DT204c, and
DT49 and laboratory strain SL1344 (4). Based on the association
of SopE with an epidemic S. Typhimurium clone, it has been
speculated that acquisition of the SopE protein by phage-
mediatedhorizontalgenetransfermighthaveincreasedtheﬁtness
of the resulting strain in its host population (5). However, exper-
imental evidence for this hypothesis is lacking.
ThesopEgeneencodesasecretedsubstrate(effectorprotein)of
the invasion-associated type III secretion system (T3SS-1) of
S.Typhimurium(3,6).SopEactivatesseveralinnateimmunesig-
nalingpathways(6–8)andisapotentinducerofintestinalinﬂam-
mation (9, 10), but the molecular mechanisms by which SopE
might enhance the ﬁtness of an epidemic S. Typhimurium clone
remain unknown. Here we investigated whether SopE increases
the ﬁtness of S. Typhimurium in a mouse colitis model and eluci-
dated the underlying mechanism.
RESULTS
SopE enhances growth in the inﬂamed intestine. The sopE gene
increases the severity of intestinal inﬂammation (8, 10), and this
host response enhances the luminal growth of S. Typhimurium
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mightincreasethebacterialnumbersinthegutcontents.Weused
S. Typhimurium strain SL1344 (13), which carries the SopE
prophage (3), to investigate whether acquisition of the sopE gene
enhances the ﬁtness of the pathogen in the mouse colitis model
(14). In this model, genetically susceptible mice (C57BL/6) are
givenstreptomycin24hpriortoS.Typhimuriumadministration.
Treatment of mice with streptomycin prior to bacterial inocula-
tion disrupts the resident microbiota to allow S. Typhimurium to
elicit a pathology similar to human gastroenteritis (14). A previ-
ous study found the SL1344 wild type and a derivative carrying
mutations in invG (resulting in inactivation of T3SS-1) and sseD
(resulting in inactivation of T3SS-2) are recovered in equal num-
bersfromintestinalcontentsduringtheﬁrst3daysafterinfection
inthemousecolitismodel(12).However,atday4afterinfection,
mice infected with the SL1344 wild type, which elicits intestinal
inﬂammation, contain signiﬁcantly higher numbers of S. Typhi-
murium bacteria in their intestinal contents than mice infected
with an invG sseD mutant which does not elicit intestinal inﬂam-
mation (12). To determine whether sopE contributes to this
inﬂammation-inducedgrowthadvantage,weusedgroupsofmice
(C57BL/6) preconditioned by treatment with streptomycin and
infected with an SL1344 strain marked with an antibiotic resis-
tance cassette (phoN::Kan, CAL63), here referred to as the wild
type,orwithanisogenicmutantlackingthesopEgene(phoN::Kan
sopE, CAL88). Four days after infection, the colon contents of
mice infected with the sopE-carrying wild-type strain (CAL63)
containedsigniﬁcantlyhighernumbers(P0.05)ofS.Typhimu-
rium than the colon contents of mice infected with the isogenic
sopE mutant (CAL88) (Fig. 1A), suggesting that the presence of
SopEsigniﬁcantlyenhancestheabilityofS.TyphimuriumSL1344
togrowintheintestinallumen.ThisistheﬁrsttimeSopEhasbeen
shown to enhance luminal growth of S. Typhimurium in the in-
ﬂamed gut.
SopE enhances iNOS expression. One mechanism by which
S. Typhimurium can edge out competing microbes in the in-
ﬂamed intestine is growth by anaerobic tetrathionate respiration
(15). To test whether SopE enhances the growth advantage con-
ferred by tetrathionate respiration, we infected streptomycin-
pretreated mice (C57BL/6) with an equal mixture of the SL1344
wildtype(CAL63)andanisogenicmutantdefectivefortetrathio-
nate respiration (ttrA mutant, CAL66). Surprisingly, both strains
were recovered in similar numbers from colon contents 4 days
afterinfection(datanotshown),indicatingthattetrathionateres-
piration did not enhance the luminal growth of an S. Typhimu-
rium SopE lysogen. Similar results were obtained with geneti-
cally resistant (CBA/J) mice, which develop intestinal
inﬂammation slowly, within 1 to 2 weeks after S. Typhimurium
infection in the absence of streptomycin pretreatment. The S. Ty-
phimurium SL1344 wild type (CAL63) and its isogenic ttrA mu-
tant (CAL66) were recovered in similar numbers from the feces
over time (see Fig. S1 in the supplemental material). In contrast,
an S. Typhimurium strain naturally lacking the SopE prophage
(IR715) was recovered from fecal contents of CBA mice in signif-
icantly higher numbers than its isogenic ttrA mutant (SW661)
starting as early as day 5 after infection and continuing through-
out the remainder of the experiment (see Fig. S1 in the supple-
mental material).
FIG 1 The sopE gene induces iNOS expression and enhances the growth of S. Typhimurium in the intestine. Groups of streptomycin-pretreated mice were
infectedwiththeSL1344wildtype(CAL63,sopE)orasopEmutant(CAL88,sopE).Groupsofmicewereeuthanizedattheindicatedtimepoints.Forallgroups,
n  4 except for the day 2 sopE group (n  3) (a) Analysis of bacterial numbers in the colon contents. Boxes in whisker plots represent the second and third
quartiles,whilelinesindicatetheﬁrstandfourthquartiles.(B)Nos2mRNAlevelsinthemucosawerequantiﬁedbyreal-timePCR.Barsrepresentgeometricmean
Nos2 copy numbers per 100 copies of glyceraldehyde 3-phosphate dehydrogenase (Gapdh) mRNA  the standard errors. (C) Levels of iNOS protein in the
mucosafrommiceinfectedwithsopE(lanes1to4)orsopEmutant(lanes5to8)strainsweredeterminedbyWesternblotting(toppanel).Detectionoftubulin
by Western blotting served as a loading control (bottom panel). Each lane represents protein extracts isolated from one animal. Molecular masses of standard
proteins are indicated on the right. (D) Quantiﬁcation of iNOS levels in Western blot assays by densitometry. Each square represents the intensity of the iNOS
signal divided by the intensity of the tubulin signal from one animal. Signiﬁcance is based on the two-tailed Student t test. *, P  0.05.
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analyzed the cecal immune response elicited by S. Typhimurium
strain SL1344 in the mouse colitis model. We noticed that the
SL1344 wild type (CAL63) induced Nos2 gene expression at sig-
niﬁcantly higher levels than a sopE mutant (CAL88) at day 3 after
the infection of streptomycin-pretreated C57BL/6 mice (Fig. 1B),
although the Nos2 mRNA levels in the two groups were similar at
day 4 after infection. Nos2 encodes inducible nitric oxide (NO)
synthase (iNOS), which was present at signiﬁcantly (P  0.05)
higher levels in the cecal mucosa 3 days after infection with the
wild type (CAL63) than after infection with a sopE mutant
(CAL88), as shown by immunoblotting (Fig. 1C) followed by
quantiﬁcation by densitometry (Fig. 1D). Thus, the SopE-
mediated growth advantage observed 4 days after infection
(Fig. 1A) was preceded by a SopE-mediated increase in iNOS ex-
pression at day 3 after infection (Fig. 1B to D).
Nitrate is a negative regulator of tetrathionate respiration.
The activity of iNOS generates NO, which reacts with reactive
oxygenspecies(ROS)toformperoxynitrite(ONOO),abacteri-
cidal reactive nitrogen species that quickly isomerizes to harmless
nitrate (NO3
) (16). Nitrate is the preferred anaerobic electron
acceptor of Salmonella serotypes (17), presumably because the
relatively high standard redox potential (E0) of the nitrate-nitrite
redox couple (E0  433 mV) makes this electron acceptor ener-
getically favorable over the tetrathionate-thiosulfate couple,
which has a lower E0 (170 mV) (18). To test whether the presence
of nitrate is sufﬁcient to suppress the growth advantage conferred
by tetrathionate respiration, mucin broth containing tetrathion-
ate and various concentrations of nitrate was inoculated with an
equalmixtureoftheKanrSL1344wild-typestrain(CAL63)andan
isogeniccarbenicillin-resistant(Carbr)ttrAmutant(CAL66).Ad-
dition of nitrate diminished the growth advantage conferred by
tetrathionate respiration in mucin broth containing tetrathionate
(Fig. 2A). These data suggested that in the presence of the ener-
getically preferred nitrate, the growth beneﬁt conferred by tetra-
thionate respiration was diminished.
SopE changes ttrA gene expression during infection. One
possible scenario to explain the above observations is that SopE-
inducedexpressionofiNOSinthececalmucosageneratesnitrate,
which in turn suppresses the expression of tetrathionate utiliza-
tion genes (ttrBAC) in the inﬂamed gut. To test this idea, we ex-
tracted bacterial RNA from the intestinal contents of mice 4 days
after infection with the SL1344 wild-type strain (CAL63) or with
an isogenic sopE mutant (CAL88) (mouse colitis model). Relative
levels of expression of the ttrA mRNA, which encodes the large
subunit of the tetrathionate reductase complex, were determined
by quantitative real-time PCR and normalized to the abundance
of S. Typhimurium 16S rRNA (15). Remarkably, expression of
ttrA was signiﬁcantly lower in the SopE-expressing SL1344 wild
type (CAL63) than in the sopE mutant (CAL88) (Fig. 2B). These
data suggested that the presence of the sopE gene markedly re-
duced the expression of ttrA in luminal S. Typhimurium in vivo.
SopE enhances nitrate respiration-dependent growth of
S.Typhimurium.S.Typhimuriumcanutilizenitrateasaterminal
electron acceptor (17, 19). We therefore reasoned that the intesti-
nalgrowthadvantageconferredbySopE(Fig.1A)mightbedueto
anaerobicnitraterespiration.Totestthishypothesis,wegenerated
a nitrate respiration-deﬁcient mutant of SL1344. Three operons,
including narGHJI, narZYWV, and napFDAGHBC, contribute to
nitrate reductase activity in S. Typhimurium (20, 21). We dis-
rupted the narG, narZ, and napA genes in SL1344 to create a mu-
tant (CAL55) that completely lacked respiratory nitrate reductase
activity (Fig. 3A). Anaerobic coculture of the Kanr SL1344 wild
type (CAL63) with the isogenic Carbr narG narZ napA mutant
(CAL64) in mucin broth resulted in enrichment for the wild type
when the medium was supplemented with nitrate but not when
nitrate was absent (Fig. 3B).
To investigate whether nitrate respiration genes confer a
growthbeneﬁtintheinﬂamedintestine,weusedthemousecolitis
model and infected C57BL/6 mice with an equal mixture of the
SL1344 wild-type strain (CAL63) and the isogenic, nitrate
respiration-deﬁcient mutant (narG narZ napA mutant, CAL64).
S. Typhimurium infection resulted in acute intestinal inﬂamma-
tion (Fig. 4A and B) and markedly increased levels of mRNAs for
genes that encode proinﬂammatory cytokines (keratinocyte-
FIG2 Inhibition of tetrathionate respiration by nitrate and SopE. (A) Mucin
brothcontainingtheindicatedconcentrationsofnitrateandtetrathionatewas
inoculated with an equal mixture of the SL1344 wild-type strain (wt, CAL63)
and a ttrA mutant (CAL66). Bacterial numbers were determined after 16 h of
anaerobicgrowth.Barsrepresentgeometricmeansofthecompetitiveindex
thestandarderrors.Resultsareaveragesofthreeindependentexperiments.(B)
Groupsofstreptomycin-pretreatedmice(n4pergroup)wereinfectedwith
the SL1344 wild type (CAL63, sopE)o rasopE mutant (CAL88, sopE), and
bacterial RNA was extracted from cecal contents 4 days after infection. The
relative levels of ttrA mRNA were quantiﬁed by real-time PCR, normalized to
the abundance of S. Typhimurium 16S rRNA, and expressed as n-fold differ-
ences from the ttrA mRNA levels present in the SL1344 wild type (CAL63,
sopE). Bars represent geometric means  standard errors. Signiﬁcance is
based on the two-tailed Student t test. **, P  0.01; *, P  0.05; ns, P  0.05.
FIG3 InactivationofnitratereductasesinS.Typhimurium.(A)Detectionof
nitrate reductase activity in the S. Typhimurium wild type (SL1344) and a
narGnarZnapAmutant(CAL59).Brieﬂy,thenitratereductaseassaymeasures
the reduction of nitrate to nitrite with methyl viologen as an electron donor.
Nitrate is added to the reaction medium containing lysed bacterial cells, and
nitrite (from nitrate reductase activity) is measured on the basis of its forma-
tion of a colored azo compound, which is quantiﬁed with a spectrophotome-
ter. (B) Mucin broth was inoculated with an equal mixture of the SL1344
wild-type strain (wt, CAL63) and a narG narZ napA mutant (CAL64). Com-
petitive indices for anaerobic growth in mucin broth with () or without ()
nitrateareshown.Barsrepresentgeometricmeansstandarderrors.Thedata
are from three independent experiments. Signiﬁcance is based on the two-
tailed Student t test. **, P  0.01.
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gamma interferon [IFN-]) (Fig. 4C). Four days after infection,
the SL1344 wild-type strain (CAL63) was recovered in higher
numbers than the narG narZ napA mutant (CAL64) (Fig. 4D).
Similar results were obtained in the absence of streptomycin pre-
treatment when genetically resistant (CBA/J) mice were infected
with an equal mixture of CAL63 and CAL64. Outgrowth of the
nitrate respiration-competent strain (CAL63) was observed start-
ing day 16 after infection in this model (see Fig. S2 in the supple-
mental material).
Interestingly, when streptomycin-pretreated C57BL/6 mice
wereinfectedwithanequalmixtureofaKanrSL1344sopEmutant
(CAL88) and a Carbr sopE narG narZ napA mutant (CAL89), the
growth advantage conferred by nitrate respiration was signiﬁ-
cantly (P  0.01) diminished (Fig. 4D). Collectively, these data
suggested that the presence of the sopE gene signiﬁcantly en-
hanced the luminal growth advantage conferred by nitrate respi-
ration genes.
S. Typhimurium causes intestinal inﬂammation by deploying
T3SS-1 for epithelial invasion and T3SS-2 to promote macro-
phage survival (14, 22, 23). Inactivation of T3SS-1 (through a
mutation in invA) and T3SS-2 (through a mutation in spiB) ren-
ders S. Typhimurium unable to trigger intestinal inﬂammation
(24). To determine whether nitrate respiration supports luminal
growth in the absence of inﬂammation, streptomycin-pretreated
C57BL/6 mice were infected with an equal mixture of a Kanr invA
spiB mutant (CAL86) and a Carbr invA spiB narG narZ napA mu-
tant (CAL85). Mice infected with this mixture neither developed
intestinal pathology (Fig. 4A and B) nor exhibited elevated levels
of mRNAs for genes that encode proinﬂammatory cytokines
(Fig. 4C). The equal recovery of both strains from colon contents
4 days after infection suggested that nitrate respiration provided
little growth beneﬁt in the absence of intestinal inﬂammation
(Fig. 4D).
GrowthofS.Typhimuriumisdrivenbyhost-derivednitrate.
To further investigate the signiﬁcance of SopE-mediated induc-
tionofiNOSexpressionduringinfection(Fig.1BtoD),wild-type
mice(C57BL/6)oriNOS-deﬁcientmice(i.e.,micecarryingamu-
tation in Nos2) were infected with an equal mixture of the Kanr
SL1344 wild-type strain (CAL63) and the isogenic, nitrate
respiration-deﬁcient Carbr mutant (narG narZ napA mutant,
CAL64). As expected, iNOS expression was detected in wild-type
mice but not in iNOS-deﬁcient mice (Fig. 5A) but both groups
exhibited similarly severe pathological changes 4 days after S. Ty-
phimurium infection (Fig. 5B and C). While a growth advantage
of the wild type (CAL63) over the narG narZ napA mutant
(CAL64) was observed in wild-type mice, no enrichment for the
S. Typhimurium wild-type strain was observed in Nos2-deﬁcient
mice (Fig. 5D; P 0.01). These data suggested that host-derived
FIG 4 The sopE gene boosts nitrate respiration-dependent growth in vivo. Groups of streptomycin-pretreated mice (n  4 per group) were inoculated with
sterile medium (mock) or with equal mixtures of S. Typhimurium SL1344 derivatives (relevant genotypes are indicated), and organs were collected for analysis
4 days after infection. (A) Blinded histopathology scoring of cecal inﬂammation showing average scores (bars) and scores of individual animals (squares). (B)
Representative images of sections from the cecal mucosa. (C) Expression of proinﬂammatory markers in the cecal mucosa was determined by quantitative
real-time PCR analysis. Bars represent geometric mean KC-, tumor necrosis factor alpha-, and IFN--encoding (Kc, Tnfa, and Ifng, respectively) mRNA copy
numbersper100,000copiesofglyceraldehyde3-phosphatedehydrogenase(GAPDH)mRNAthestandarderrors.(D)CompetitiveindicesofS.Typhimurium
strains recovered from the colon contents of infected mice. Bars represent geometric means  standard errors. Signiﬁcance is based on the two-tailed Student
t test. **, P  0.01.
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growth of S. Typhimurium.
Horizontal transfer of the SopE prophage enhances
growth by nitrate respiration. SopE is encoded by a mobile ge-
netic element, lysogenic SopE, that can be transferred horizon-
tally between different strains (5, 25). To recapitulate phage-
mediatedhorizontaltransferofthesopEgene,wedeterminedhow
intestinalgrowthofS.TyphimuriumIR715isalteredbylysogeni-
zation with SopE. We infected mice with an equal mixture of
IR715 with an isogenic nitrate respiration-deﬁcient mutant
(IR715 narG narZ napA mutant, CAL50) (mouse colitis model).
Four days after infection, mice exhibited acute intestinal inﬂam-
mation (Fig. 6A and B) and elevated levels of mRNAs for genes
that encode proinﬂammatory cytokines (Fig. 6C). Nitrate respi-
ration conferred a small growth advantage, as indicated by the
recovery of higher numbers of the S. Typhimurium wild type
(IR715) than of the isogenic nitrate respiration-deﬁcient mutant
(IR715 narG narZ napA mutant, CAL50) (Fig. 6D). This nitrate
respiration-dependent growth advantage was not observed in
mice infected with an equal mixture of a nalidixic acid-resistant
(Nalr) IR715 invA spiB mutant (SPN452) and an IR715 invA spiB
narG narZ napA Carbr mutant (CAL87) (Fig. 6D), presumably
because these strains failed to elicit intestinal inﬂammation
(Fig. 6A to C).
WenextinfectedmicewithanequalmixtureofIR715carrying
theSopEprophage(CAL99)andanisogenicnitraterespiration-
deﬁcientmutant(IR715SopEnarGnarZnapAmutant,CAL98)
(mouse colitis model). The growth beneﬁt conferred by nitrate
respiration genes was signiﬁcantly (P  0.05) greater in strains
lysogenized by the SopE prophage (CAL99 versus CAL98) than
in strains lacking the SopE prophage (IR715 versus, CAL50)
(Fig. 6D). These data suggested that horizontal transfer of SopE
signiﬁcantlyenhancedtheluminalgrowthadvantageconferredby
nitraterespirationinthemousecolitismodel.Toexcludethepos-
sibility that other genes carried by the SopE prophage contrib-
uted to the enhancement of S. Typhimurium growth by nitrate
respiration, we repeated the experiment after deleting the sopE
gene. Mice were infected with an equal mixture of IR715 carrying
a SopE prophage derivative in which the sopE gene had been
deleted (IR715 SopE sopE mutant, CAL102) and an isogenic
nitrate respiration-deﬁcient mutant (IR715 SopE sopE narG
narZ napA mutant, CAL103) (mouse colitis model). Deletion of
the sopE gene (CAL102 versus CAL103) reduced the luminal
growth advantage conferred by nitrate respiration to levels ob-
served in strains lacking the SopE prophage (IR715 versus,
CAL50) (Fig. 6D). The reduced competitive advantage was not
due to lessened inﬂammation, as both the histopathology scores
and levels of inﬂammatory cytokines of the groups were similar
(Fig. 6A to C).
Taken together, these results indicated that SopE-mediated
horizontal transfer of the sopE gene could increase the luminal
abundance of S. Typhimurium by boosting growth through ni-
trate respiration.
DISCUSSION
SopE is a T3SS-1 effector protein (26) that enhances intestinal
inﬂammationduringS.Typhimuriuminfection(9,10)byactivat-
ing caspase 1, which in turn cleaves the immature forms of
interleukin-1 (IL-1) and IL-18 into biologically active cyto-
kines (7, 8). During S. Typhimurium infection, IL-18 contributes
to the early production of IFN- (27), a cytokine that is a potent
inducer of iNOS expression (28–31). Here we show that the pres-
ence of the sopE gene resulted in a signiﬁcant increase in mucosal
iNOS production 3 days after S. Typhimurium infection in the
mousecolitismodel.NOgeneratedbyiNOScanreactwithROSto
form peroxynitrite (ONOO), which isomerizes to nitrate
FIG5 Nitratedrivinganaerobicrespirationishostderived.Groups(n4)ofstreptomycin-pretreatedwild-type(WT)mice(C57BL/6)oriNOS-deﬁcientmice
(Nos2)wereinoculatedwithanequalmixtureofanS.TyphimuriumSL1344wild-typestrain(CAL63)andanarGnarZnapAmutant(CAL64),andorganswere
collected4daysafterinfection.(A)LevelsofmucosaliNOSproteininwild-type(lanes1to4)andiNOS-deﬁcientmice(lanes5to8)weredeterminedbyWestern
blotting (top). Detection of tubulin by Western blotting served as a loading control (bottom). Each lane represents protein extracts isolated from one animal.
Molecular masses (kilodaltons [kd]) of standard proteins are indicated on the right. (B) Representative images of sections from the cecal mucosa. (C) Blinded
histopathology scoring of cecal inﬂammation showing average scores (bars) and scores of individual animals (squares). (D) Competitive indices of S. Typhi-
murium strains recovered from the colon contents of infected mice. Bars represent geometric means  standard errors. Signiﬁcance is based on the two-tailed
Student t test. **, P  0.01.
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) (16), a terminal electron acceptor that can promote the
growth of S. Typhimurium by anaerobic nitrate respiration (17,
19).TheelevatedmucosaliNOSproductionobserved3daysafter
infection was followed the next day by a nitrate respiration-
dependent luminal growth advantage of sopE-positive S. Typhi-
murium. This nitrate respiration-dependent luminal growth ad-
vantage was abrogated in iNOS-deﬁcient mice. The picture
emerging from these data is that SopE-dependent iNOS expres-
sion generates host-derived nitrate, which in turn boosts the lu-
minal growth of S. Typhimurium in the inﬂamed intestine
through nitrate respiration (Fig. 7).
ThesopEgeneiscarriedbyabacteriophage,termedSopE(3),
that is absent from most S. Typhimurium isolates (4). The pres-
ence of SopE in an S. Typhimurium clone that caused an epi-
demic in cattle and humans in Europe in the 1980s suggests that
the ﬁtness of this epidemic clone might have been increased by
phage-mediated horizontal transfer of the sopE gene (5). Here we
show that transfer of SopE into a SopE-negative S. Typhimu-
rium isolate (ATCC 14028) increased its ﬁtness by conferring a
nitrate respiration-dependent luminal growth advantage.
In Escherichia coli, genes for anaerobic respiration are subject
to a hierarchical control that ensures that the respiratory electron
acceptor with the most positive E0 is used preferentially (32–38).
The nitrate-nitrite redox couple is a terminal electron acceptor
with a higher E0 (433 mV) (39) than the tetrathionate-thiosulfate
couple(E0170mV)(18).Hereweshowthatnitrateisanegative
regulator of anaerobic tetrathionate respiration in vitro. Further-
more, the presence of the sopE gene signiﬁcantly reduced the ex-
pression of tetrathionate respiration genes in the luminal S. Ty-
phimurium population in vivo. This hierarchical control of genes
involved in anaerobic respiration might ensure that the energeti-
cally preferred terminal electron acceptor is used preferentially to
maximize the growth rate in the competitive environment of the
large bowel.
The observation that tetrathionate provides a growth advan-
tage in the inﬂamed intestine (40) is not germane to host interac-
tions of the majority of the members of the family Enterobacteri-
aceae, because tetrathionate respiration is a signature trait
historically used to differentiate Salmonella serotypes from most
other bacteria (41). In contrast, the concept that nitrate respira-
tion can provide a growth beneﬁt during intestinal inﬂammation
isrelevanttootherhost-microbeinteractions,sincenitratereduc-
FIG 6 Horizontal transfer of the SopE prophage boosts nitrate respiration-dependent growth in vivo. Groups of streptomycin-pretreated mice (the number
of mice in each group is shown in panel A) were inoculated with sterile medium (mock) or with equal mixtures of S. Typhimurium ATCC 14028 derivatives
(relevant genotypes are indicated), and organs were collected for analysis 4 days after infection. (A) Blinded histopathology scoring of cecal inﬂammation
showing average scores (bars) and scores of individual animals (squares). (B) Representative images of sections from the cecal mucosa. (C) Expression of
proinﬂammatorymarkersinthececalmucosawasdeterminedbyquantitativereal-timePCRanalysis.Barsrepresentgeometricmeansofn-foldchangesinKC-,
tumornecrosisfactoralpha-,andIFN--encoding(Kc,Tnfa,andIfng,respectively)mRNAlevelsovermRNAlevelsinmock-infectedmicethestandarderrors.
(D)Competitiveindices(CI)ofS.Typhimuriumstrainsrecoveredfromthecoloncontentsofinfectedmice.Barsrepresentgeometricmeansstandarderrors.
Signiﬁcance is based on the two-tailed Student t test. *, P  0.05; **, P  0.01. WT, wild type.
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nitrate respiration enhances the ability of Campylobacter jejuni to
colonize the chicken cecum (42). In the genitourinary tract, Neis-
seriagonorrhoeaehasbeenhypothesizedtousenitriteasaterminal
electron acceptor to survive in anoxic environments alongside
strict anaerobes (43). Finally, nitrate respiration has been postu-
lated to contribute to the successful colonization of anoxic mi-
croenvironments in the respiratory tract by Mycobacterium bovis
and Pseudomonas aeruginosa (44, 45). However, this is the ﬁrst
study to ﬁnd a direct effect of a T3SS effector protein, SopE, in
manipulating the host to provide a terminal electron acceptor for
use in respiration. The degree to which other bacteria may use
effector proteins or other virulence factors to manipulate host
production of terminal electron acceptors will be an exciting area
of future research.
MATERIALS AND METHODS
Bacterial culture conditions. For the Escherichia coli and S. Typhimu-
riumstrainsusedinthisstudy,seeTableS1inthesupplementalmaterial.
Strains were routinely grown in LB broth (10 g/liter tryptone, 5 g/liter
yeast extract, 10 g/liter) or on LB plates (15 g/liter agar) with the appro-
priate antibiotic at the following concentrations: Carb, 0.1 mg/ml; Cm,
0.03mg/ml;Kan,0.1mg/ml;Nal,0.05mg/ml;tetracycline(Tet),0.02mg/
ml.
TransductionusingphageP22.Oncesinglemutationswereobtained
inanS.Typhimuriumstrain,phagelysatesweregenerated.Weincubated
1mlofanovernightcultureofthestrainofinterestwith4mlofP22broth
(LBbrothsupplementedwith1	Eminimalmedium[46],0.2%glucose,
and 1010 to 1011 PFU/ml P22 HT-int) overnight at 37°C. Debris was re-
moved by centrifugation at 10,000 	 g for 5 min, and the phage-
containing supernatant was mixed with chloroform (20% ﬁnal volume)
and stored at 4°C. To transfer mutations between strains, diluted phage
lysate containing the mutation of interest was incubated for1ha troom
temperature with an overnight culture of the recipient bacterial strain.
Thebacteriawerethenspreadontoplateswiththeappropriateantibiotic.
Resulting colonies were streaked onto Evans blue uranine agar plates
(10 g/liter tryptone, 5 g/liter yeast extract, 5 g/liter NaCl, 2.5 g glucose,
15 g/liter Difco agar, 0.00125% Evans blue solution, 0.5% K2HPO4,
0.0025% sodium ﬂuorescein) to select for nonlysogenic colonies. The
sensitivity of the resulting strains to reinfection with P22 was determined
by cross-streaking of the bacterial strain with P22 H5.
Construction of S. Typhimurium mutants. To construct the napA
mutant CAL46, as well as the narZ mutant CAL40, approximately 1-kb
regions upstream and downstream of either napA or narZ were PCR am-
pliﬁed(seeTableS2inthesupplementalmaterial)anddigestedwithXbaI
(New England Biolabs). The two regions ﬂanking each target gene were
ligated and PCR ampliﬁed to obtain an approximately 2-kb region that
was inserted into pCR2.1 with a TOPO cloning kit (Invitrogen), creating
plasmids pCAL3 and pCAL1, respectively. The insertions were then se-
quenced.TheplasmidswerenextdigestedwithSphItoexcisethenapAor
narZ ﬂanking regions, which were then inserted into suicide plasmid
pRDH10 to obtain pCAL9 and pCAL10, respectively. These plasmids
were propagated in E. coli DH5 pir. A Kanr cassette from pUCKSAC
was inserted into the XbaI restriction site between the ﬂanking regions to
create pCAL11 and pCAL12, respectively. E. coli S17-1 pir was trans-
formed with the resulting plasmids and subsequently used for conjuga-
tion. Single homologous recombination events were selected for by
growth on Kan and Cm plates. To select for strains that had lost the
integrated plasmid, leaving the Kanr sequence in place of the target gene,
we used sucrose selection. For sucrose selection, overnight cultures of
bacteriaweregrowninLBbrothwithoutantibiotics,diluted,spreadonto
sucrose plates (5% sucrose, 8 g/liter nutrient broth, 15 g/liter agar), and
thenincubatedfor16hat30°C.Sucrose-sensitiveandKansCmsstrainsin
which the napA or narZ gene had been replaced with the Kanr cassette
were termed CAL42 and CAL34, respectively. To generate nonpolar mu-
tants, E. coli S17-1 pir was transformed with either pCAL9 or pCAL10
and conjugated with CAL42 and CAL34, respectively. Sucrose selection
was performed as described above, and Kans Cms strains in which the
napA or narZ gene had been deleted were named CAL46 and CAL40,
respectively. Nonpolar mutations were conﬁrmed by PCR. The napA
andnarZmutationsweretransientlymarkedwithCmrbyreintroducing
pCAL9 or pCAL10 into the chromosome of CAL46 and CAL40 to create
CAL117 and CAL45, respectively.
To construct the narG mutant CAL27, an approximately 500-bp re-
gion within the narG sequence was PCR ampliﬁed and digested with the
restriction enzymes XbaI and SphI. The digested fragment was subse-
quently cloned into pGP704 and propagated in E. coli S17-1 pir. The
resultingplasmid,pCAL5,wasintroducedintotheIR715chromosomeby
conjugation, selecting for single homologous recombination events by
plating on plates containing Carb. Mutations were conﬁrmed via PCR.
To generate a nonpolar deletion in spiB, E. coli S17-1 pir was trans-
formed with pSPN56 and conjugated with SPN450. Integration of
pSPN56intoSPN450wasselectedforbyplatingonLBcontainingCmand
Nal. Sucrose selection was used to select for the loss of pSPN56. Colonies
werescreenedforsensitivitytoCmandKan,andacolonyexhibitingboth
phenotypes was conﬁrmed by PCR to contain an unmarked spiB locus,
yielding SPN456. To enable transduction of the unmarked spiB deletion,
pSPN56 was integrated into SPN456 by conjugation as described above,
resulting in a merodiploid spiB state ﬂanking the integrated plasmid, a
state that was maintained by selection for Cmr. A transconjugant exhib-
iting Cmr and loss of the PCR product from unmarked spiB ampliﬁca-
tion was termed SPN458 (spiB::pSPN56).
To construct the sopE mutant SW976, DNA regions upstream and
downstreamofsopEwerePCRampliﬁedanddigestedwithXbaI.Thetwo
ﬂanking regions were ligated, PCR ampliﬁed, and cloned into pRDH10
using BamHI restriction enzyme sites to create pSW245. To create
FIG7 ModelofthechainofeventsbywhichSopEboostsnitraterespiration-
dependent growth of S. Typhimurium in the inﬂamed intestine. For an expla-
nation,seethetext.DUOX2,dual-oxidase2ofepithelialcells;NOX1,NADPH
oxidase 1 of epithelial cells; PHOX, NADPH oxidase of phagocytes.
SopE Boosts Growth by Nitrate Respiration
May/June 2012 Volume 3 Issue 3 e00143-12
® mbio.asm.org 7pSW246, a Kanr cassette was cloned into the XbaI site between the two
sopE ﬂanking regions in pSW245. These plasmids were conjugated from
E.coliS17-1pirintoS.Typhimurium.Plasmidintegrationintothechro-
mosome was veriﬁed by PCR. The sopE gene in SL1344 was deleted by
introducing pSW246 into SL1344(pSW172) by conjugation, selecting for
exconjugants on LB plates containing Carb and Kan. To ensure stable
replication of the temperature-sensitive plasmid pSW172, conjugation
experiments involving SL1344(pSW172) were performed at 30°C.
pSW172 was subsequently cured by growth at 37°C. A Kanr Cms Carbs
strain indicated that sopE had been replaced with Kanr and was termed
SW975.
TocreateanonpolardeletionofsopE,pSW245wasintegratedintothe
chromosome of SW975 by conjugation, selecting for concomitant Kanr
and Cmr. Sucrose selection was then used to obtain a Kans Cms strain
named SW976. The sopE deletion was marked with Cmr by conjugating
SW976 with E. coli S17-1 pir containing pSW245. The Cmr strain was
termed CAL74.
The narG::pCAL5, narZ::pCAL10, and napA::pCAL9 mutations
were transduced from CAL27, CAL45, andCAL117, respectively, into
IR715. pCAL10 and pCAL9 were removed via sucrose selection, and the
resulting strain was designated CAL50. The invA::Tetr and spiB::
pSPN56 mutations were transduced from SW562 and SPN458, respec-
tively, into CAL50, pSPN56 was removed via sucrose selection, and the
resulting strain was designated CAL87. The SopE prophage from
AJB719wastransducedintoIR715andCAL50toyieldstrainsCAL99and
CAL98, respectively. CAL63 was created by transducing the phoN::Kanr
mutationintoSL1344.ThenarG,napA,andnarZmutationsfromCAL27,
CAL45, and CAL117 were transduced into SL1344 and CAL63, and plas-
mids pCAL10 and pCAL9 were removed via sucrose selection to yield
eithermutantsdefectiveforasinglenitratereductase(designatedCAL65,
CAL51, and CAL67, respectively) or nitrate reductase-deﬁcient mutants
(CAL59 and CAL64). The invA::Tetr and spiB::pSPN56 mutations were
transduced from SW562 and SPN458 into strains CAL63 and CAL64,
pSPN56 was removed via sucrose selection, and the resulting strains were
designated CAL86 and CAL85, respectively. Additionally, the sopE::
pSW245 mutation was transduced from CAL74 into strains CAL63,
CAL64, CAL98, and CAL99 and the integrated plasmid pSW245 was re-
movedviasucroseselectiontocreatestrainsCAL88,CAL89,CAL102,and
CAL103, respectively. The ttrA::pSW171 mutation was transduced from
SW661 into CAL63 to yield CAL66.
Respiratorynitratereductaseassay.Bacterialovernightcultureswere
diluted 1:100 in LB broth containing 40 mM NaNO3 and grown statically
f o r3ha t37°C. The assay was performed as described previously (38).
Relative nitrate reductase activity was calculated as previously described
(38).
Competitive growth assays. Competition assays were performed in
mucin broth containing 0.25% type II porcine mucin (Sigma-Aldrich),
40 mM morpholinepropanesulfonic acid (MOPS) buffer, trace elements
(47) and magnesium sulfate (265 mg/liter) dissolved in sterile water. So-
dium tetrathionate (Sigma-Aldrich) or sodium nitrate (Sigma-Aldrich)
dissolvedinsterilewaterwasaddedattheindicatedconcentrations.A1:1
ratio of two overnight bacterial strains at a ﬁnal concentration of 1 	
105 CFU was used to inoculate 14 ml of mucin medium into a 15-ml
screw-topconicaltube.Cultureswerestaticallyincubatedat37°Cfor24h
and then placed on ice. Bacterial numbers were determined by plating
serial dilutions on the appropriate antibiotics. In vitro competition assays
were performed in triplicate with different colonies.
Mouseexperiments.TheInstitutionalAnimalCareandUseCommit-
tee at the University of California, Davis, approved all animal experi-
ments. For the mouse colitis model, either wild-type C57BL/6J or iNOS-
deﬁcientB6.129P2-Nos2tm1Lau/Jmice(JacksonLaboratories,BarHarbor,
ME) were given streptomycin at 20 mg/mouse in 0.1 ml sterile water
intragastrically 24 h prior to inoculation with bacteria as described previ-
ously(14).Incompetitionexperiments,a1:1ratioofcompetingstrainsat
aﬁnalconcentrationof1	108CFU/mousein0.1mlLBbrothwasgiven
intragastrically.Insingleinfections,1	108CFU/mouseofasinglestrain
in0.1mlLBbrothwasgivenintragastrically.Miceweresacriﬁcedbetween
1 and 4 days after infection as indicated. Cecal tissue and cecal contents
were ﬂash frozen and stored at 80°C. Colon contents were stored in
phosphate-buffered saline (PBS) on ice. CFU counts were determined by
plating dilutions of the inoculum or colon content on selective medium.
InthemodelofextendedS.Typhimuriuminfection,wild-typeCBA/J
mice (Jackson Laboratories) were intragastrically provided an inoculum
containing a 1:1 ratio of competing strains at a ﬁnal concentration of 1 	
108CFU/mousein0.1mlLBbroth.Fecalpelletswerecollectedbetween1
and28dayspostinfectionasindicatedandstoredinPBSonice.Attheend
of the experiment, mice were euthanized and colon contents were re-
moved and stored in PBS on ice. CFU counts were determined by plating
dilutions of the inoculum, fecal pellets, or colon content on selective me-
dium.
Histopathology. The distal segment of the cecum was ﬁxed in 10%
buffered formalin phosphate and stained with hematoxylin and eosin. A
veterinary pathologist scored histopathological changes by blinded scor-
ing of sections by a scheme described previously (48).
Isolation of cecal RNA and proteins. Tissue was homogenized in a
Mini-Beadbeater(BioSpecProducts,Bartlesville,OK),andRNAandpro-
tein were isolated by the TRI-Reagent method (Molecular Research Cen-
ter, Inc.) following the manufacturer’s protocol. DNA remaining in the
RNA isolation portion was removed using the DNA-free kit (Applied
Biosystems). RNA samples and protein extracts were stored at 80°C or
20°C, respectively.
Quantiﬁcation of mRNA levels. Isolated RNA was normalized to
100 ng/l and reverse transcribed using random hexamers and Moloney
murineleukemiavirusreversetranscriptase(AppliedBiosystems).Quan-
titative real-time PCR was performed using SYBR green (Applied Biosys-
tems) PCR mix and the appropriate primer sets (see Table S2 in the sup-
plemental material) at a ﬁnal concentration of 0.25 mM. In cases where
n-fold changes were calculated, relative expression was compared to ei-
ther mock-infected cecal tissue for murine gene expression experiments
or to SopE-positive S. Typhimurium for bacterial gene expression analy-
sis. In cases where absolute values were calculated, a standard curve was
used.Tocreatethestandards,ﬁrstweusedastandardPCRtoamplifythe
target gene fragment with the quantitative reverse transcription (qRT)-
PCRprimersandinsertingitintopCR2.1byusingtheTOPOcloningkit.
The resulting plasmids were sequenced. The plasmids were quantiﬁed to
create a set of standards ranging from 108 to 101 copies/l diluted in a
0.02-mg/ml yeast RNA (Sigma) solution. Each qRT-PCR was performed
in duplicate.
Analysis of cecal proteins. The concentration of mouse cecal protein
wasmeasuredusingaMicroBCAproteinassaykit(Pierce)inaccordance
with the manufacturer’s instructions. A 0.05-mg sample of protein was
separated by SDS-PAGE and transferred to a polyvinylidene ﬂuoride
membrane(Millipore).Threepercentnonfatdriedmilkand0.1%Tween
20 (Bio-Rad) in a PBS solution were used as blocking agents. To detect
iNOS,a1:1,500dilutionoftheprimaryantibody(anti-mouse;BDTrans-
duction Laboratories) in PBS with 5% bovine serum albumin (BSA) was
added to the membrane. As a loading control, /-tubulin was detected
with a 1:5,000 dilution of the primary antibody (anti-rabbit; Cell Signal-
ing) in PBS with 5% BSA. The horseradish peroxidase (HRP)-conjugated
secondary antibody (Bio-Rad), either anti-mouse or anti-rabbit, was di-
luted 1:5,000 in blocking buffer and applied to the membrane. Protein
bands were visualized by applying 0.5 ml HRP substrate solution and
imaged with a UVP BioSpectrum Imaging System. Blot density quantiﬁ-
cation was performed with the Labworks Image Acquisition and Analysis
Software (UVP version 4.6.00.0).
Statistics. The natural log of the data values was calculated before
statisticalanalysis.WeusedStudent’sttesttoassesssigniﬁcanceandcon-
sidered P values below 0.05 to be signiﬁcant.
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